Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Product categories
Product categories
Medical Treatment
Products 31 to 40 of 44
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Probiotic Yogurt Strain (Nutraceuticals)
by
Yovivo!
Biotech components:
Probiotic
Business models:
B2B
Country of production:
USA
Country of distribution:
North America
+
Africa
+
Europe
+
Asia
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/10/02 06:17 (4 years ago)
Known funding amount:
8,946 USD
Funding types:
Crowdfunding
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
Probiotic Yogurt Strain (tryptophan production in situ in gut)
by
Koliber Biosciences
Biotech components:
Probiotic
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/08/30 11:49 (4 years ago)
Known funding amount:
N/A
Funding types:
Public Funding
+
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
rHuPH20
by
Halozyme
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/10/01 09:37 (4 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
HALO
(NASDAQ)
Value chain stage:
Input
SER150DN
by
Serodus
+
Evolva
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/11/09 16:29 (4 years ago)
Known funding amount:
102,000,000 NOK
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
+
More information needed
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Sitagliptin
by
Codexis
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/08/30 11:49 (4 years ago)
Known funding amount:
37,000,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
CDXS
(NASDAQ)
Value chain stage:
Input
SNS-301 (noninfectious lambda bacteriophage viruses)
by
Sensei Biotherapeutics
Biotech components:
Virus
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:40 (1 year ago)
Date last modified:
2020/12/18 14:40 (1 year ago)
Known funding amount:
28,500,000 USD
Funding types:
Private Funding
Industry:
Medical
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
+
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Vaxonella
by
Prokarium
Biotech components:
Bacteria
Business models:
B2C
Country of production:
UK
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2019/05/15 16:12 (3 years ago)
Known funding amount:
12,600,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
On the market
+
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
SYN-004 (RIBAXAMASE)
by
Synthetic Biologics
Biotech components:
Microbe
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/08/30 11:49 (4 years ago)
Known funding amount:
12,467,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
SYN
(NYSEMKT)
Value chain stage:
Finished Product
SYN-005
by
Synthetic Biologics
+
Intrexon
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/10/01 09:27 (4 years ago)
Known funding amount:
24,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYN
(NYSEMKT)
Value chain stage:
Finished Product
SYNB1020
by
Synlogic
Biotech components:
Microbe
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
+
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/08/30 11:49 (4 years ago)
Known funding amount:
125,800,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
SYBX
(NASDAQ)
Value chain stage:
Finished Product
1
2
3
4
5
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
